Iovance Biotherapeutics
IOVA
IOVA
299 hedge funds and large institutions have $798M invested in Iovance Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 99 increasing their positions, 92 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6.21% less ownership
Funds ownership: 79.24% → 73.03% (-6.2%)
55% less capital invested
Capital invested by funds: $1.79B → $798M (-$989M)
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
299
Holding in Top 10
2
Calls
$7.88M
Puts
$6.57M
Top Buyers
| 1 | +$18.3M | |
| 2 | +$13.7M | |
| 3 | +$12.9M | |
| 4 |
Renaissance Technologies
New York
|
+$11.7M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7.58M |
Top Sellers
| 1 | -$31.3M | |
| 2 | -$25.9M | |
| 3 | -$13M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.69M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$8.18M |